- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ONCOLOGY INSTITUTE Aktie jetzt für 0€ handeln | |||||
| 23.07. | The Oncology Institute stock initiated with Outperform rating at Noble Capital | 17 | Investing.com | ||
| 16.07. | The Oncology Institute stock initiated with Buy rating at B.Riley | 1 | Investing.com | ||
| 16.07. | B.Riley stuft The Oncology Institute mit "Buy" ein und sieht Kursziel bei 6,00 $ | 1 | Investing.com Deutsch | ||
| 14.07. | The Oncology Institute Names Kristin England as Chief Administrative Officer | 1 | GlobeNewswire (USA) | ||
| 09.07. | The Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid Members | 2 | Insider Monkey | ||
| 30.06. | The Oncology Institute wird exklusiver Anbieter für Nevada Medicaid | 1 | Investing.com Deutsch | ||
| 30.06. | The Oncology Institute to serve as exclusive provider for Nevada Medicaid | 1 | Investing.com | ||
| 30.06. | The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada | 1 | GlobeNewswire (USA) | ||
| 06.06. | The Oncology Institute files for $50M common stock offering | 2 | Seeking Alpha | ||
| 03.06. | The Oncology Institute set to join the Russell 2000 and Russell 3000 Indexes | 4 | GlobeNewswire (USA) | ||
| 19.05. | Oncology Institute, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | BTIG sets $7 price target on The Oncology Institute stock | 2 | Investing.com | ||
| 14.05. | Oncology Institute, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 14.05. | The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance | 190 | GlobeNewswire (Europe) | CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States... ► Artikel lesen | |
| 14.05. | The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer | 154 | GlobeNewswire (Europe) | CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI"), one of the largest value-based oncology groups in the United States, announced today that Dr.... ► Artikel lesen | |
| 08.05. | The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates | 3 | GlobeNewswire (USA) | ||
| 07.05. | Oncology Institute, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.04. | The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials | 2 | GlobeNewswire (USA) | ||
| 11.04. | Oncology Institute, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.03. | The Oncology Institute reports Q4 results | 2 | Seeking Alpha |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,118 | -2,48 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,707 | +0,57 % | RedChip Companies, Inc.: Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 1, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,356 | +3,32 % | PA GOODDOCTOR (01833): NOTICE OF BOARD MEETING | ||
| MOUNTAIN VALLEY MD | 0,011 | -22,97 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,232 | +8,41 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,750 | -1,83 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| VERU | 0,410 | -2,98 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
| VOLITIONRX | 0,610 | -7,72 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
| EKSO BIONICS | 3,460 | -0,57 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 7,240 | -1,63 % | Imunon, Inc.: IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer | Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening LAWRENCEVILLE, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN)... ► Artikel lesen | |
| BEYOND AIR | 2,850 | -4,36 % | Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc. | GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,453 | +4,14 % | Novacyt S.A. - Liquidity Agreement Monthly Update & TVR | ||
| AROVELLA THERAPEUTICS | 0,051 | +2,00 % | AROVELLA THERAPEUTICS LIMITED: Proposed issue of securities - ALA |
ONCOLOGY INSTITUTE INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +1,36 % bei einem Aktienkurs von 3,720 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ONCOLOGY INSTITUTE INC finden Sie auf Wallstreet Online.